Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang General Hyperthermia Medtech is a specialized medical technology company based in Hangzhou, China, that focuses on the development and manufacturing of hyperthermia therapy systems for oncology. The company's flagship products include endogenous field hyperthermia systems and millimeter-wave therapy devices designed to treat a wide range of solid tumors and manage complications such as malignant effusions. By utilizing controlled thermal energy, their technology aims to sensitize cancer cells to traditional treatments like chemotherapy and radiotherapy, thereby improving clinical outcomes. The company integrates research, production, and sales to provide comprehensive thermal oncology solutions to hospitals and cancer centers. Zhejiang General Hyperthermia Medtech is recognized as a high-tech enterprise and plays a significant role in the advancement of non-invasive cancer therapy in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang General Hyperthermia Medtech.